These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8061686)

  • 1. Piracetam and other structurally related nootropics.
    Gouliaev AH; Senning A
    Brain Res Brain Res Rev; 1994 May; 19(2):180-222. PubMed ID: 8061686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of a steroidal component in the mechanism of action of piracetam-like nootropics.
    Mondadori C; Bhatnagar A; Borkowski J; Häusler A
    Brain Res; 1990 Jan; 506(1):101-8. PubMed ID: 2137359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nootropics on memory: new aspects for basic research.
    Mondadori C; Petschke F; Häusler A
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():102-6. PubMed ID: 2690149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
    Nomura T; Nishizaki T
    Brain Res; 2000 Jul; 870(1-2):157-62. PubMed ID: 10869513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.
    Malykh AG; Sadaie MR
    Drugs; 2010 Feb; 70(3):287-312. PubMed ID: 20166767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport.
    Naftalin RJ; Cunningham P; Afzal-Ahmed I
    Br J Pharmacol; 2004 Jun; 142(3):594-608. PubMed ID: 15148255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of the nootropic properties of piracetam and oxiracetam].
    Krylova IN; Antonova LV; Kamenskiĭ AA; Iasnetsov VV
    Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoidance facilitation by nootropics.
    Sansone M; Oliverio A
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S89-97. PubMed ID: 2616794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.
    Mondadori C; Ducret T; Borkowski J
    Behav Brain Res; 1989 May; 33(1):79-82. PubMed ID: 2736062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of scopolamine-induced alterations of choline transport across the blood-brain barrier by the nootropics piracetam and pramiracetam.
    Brust P
    Arzneimittelforschung; 1989 Oct; 39(10):1220-2. PubMed ID: 2610714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures.
    Copani A; Genazzani AA; Aleppo G; Casabona G; Canonico PL; Scapagnini U; Nicoletti F
    J Neurochem; 1992 Apr; 58(4):1199-204. PubMed ID: 1372342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the nootropic action of piracetam-like nootropics by adrenalectomy: an effect of dosage?
    Mondadori C; Ducret T; Petschke F
    Behav Brain Res; 1989 Aug; 34(1-2):155-8. PubMed ID: 2765169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nootropic drugs on brain cholinergic and dopaminergic transmission.
    Pavlík A; Benesová O; Dlohozková N
    Act Nerv Super (Praha); 1987 Mar; 29(1):62-5. PubMed ID: 3035858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical evaluation of cognition enhancing drugs.
    Schindler U
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S99-115. PubMed ID: 2694232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of piracetam and oxiracetam on the content of high-energy phosphates and morphometry of astrocytes in vitro.
    Gabryel B; Trzeciak HI; Pudełko A; Cieślik P
    Pol J Pharmacol; 1999; 51(6):485-95. PubMed ID: 10817526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do piracetam-like compounds act centrally via peripheral mechanisms?
    Mondadori C; Petschke F
    Brain Res; 1987 Dec; 435(1-2):310-4. PubMed ID: 3427459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum].
    Wustmann C; Rudolph E; Schwipper U; Ranacher B; Fischer HD; Schmidt J
    Acta Biol Med Ger; 1982; 41(6):575-9. PubMed ID: 6815946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors.
    Shiotani T; Nakamoto Y; Watabe S; Yoshii M; Nabeshima T
    Brain Res; 2000 Mar; 859(2):255-61. PubMed ID: 10719072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.
    Nicholson CD
    Psychopharmacology (Berl); 1990; 101(2):147-59. PubMed ID: 2190256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons.
    Bukanova JV; Solntseva EI; Skrebitsky VG
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):229-37. PubMed ID: 12366875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.